Home › Funds › T. Rowe Price › T. Rowe Price Small-Cap Index Fund
Fund family: T. Rowe Price · Filed by T. Rowe Price Index Trust, Inc. (CIK 858581) · SEC series S000051327
Share classes and tickers: TRCSX (C000161838), TRSYX (C000161837), TRZIX (C000219329)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 15,691 with, 73 against, 0 abstentions (not counted as with management); 4 items carried no recommendation; 12 split votes are in neither count. Shareholder proposals: 20 FOR, 24 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as T. Rowe Price’s manager page (244,024 ballot items across 112 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | T. Rowe Price | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 87.2% | 15,224 | 93.7% | 208,710 |
| Backed environmental and social shareholder proposals at US companies | n/a | 6 | 2.6% | 3,333 |
Each ballot item this fund voted is set against the votes of the other T. Rowe Price funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most T. Rowe Price funds on 101 items (2.9% of the 3,487 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most T. Rowe Price funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Alliance Laundry Holdings Inc. | 2026-06-11 | To elect Michael D. Schoeb, Phyllis A. Knight and Robert L. Verigan as Class I directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Robert L. Verigan | Withhold | FOR — 7 of 7 T. Rowe Price funds | Against | — |
| IRadimed Corporation | 2026-06-23 | Election of Directors: Joe Kiani | Withhold | FOR — 7 of 7 T. Rowe Price funds | Against | Elected, 98.9% support |
| Equity Bancshares, Inc. | 2026-04-21 | Election of Directors: Gregory L. Gaeddert | For | AGAINST — 7 of 7 T. Rowe Price funds | For | Elected, 66.8% support |
| CECO Environmental Corp. | 2026-05-27 | CECO Director Election Proposal. To vote on a proposal to elect the eight directors named in the accompanying joint proxy statement/prospectus to serve until the next annual meeting of stockholders and until their successors have been duly elected and qualified (the "CECO director election proposal" | Against | FOR — 7 of 7 T. Rowe Price funds | Against | Elected, 99.7% support |
| United States Lime & Minerals, Inc. | 2026-05-01 | To elect Directors - Nominees: L. R. Weirich | For | WITHHOLD — 6 of 6 T. Rowe Price funds | For | Elected, 95.6% support |
| United States Lime & Minerals, Inc. | 2026-05-01 | To elect Directors - Nominees: R. W. Cardin | For | WITHHOLD — 6 of 6 T. Rowe Price funds | For | Elected, 91.0% support |
| United States Lime & Minerals, Inc. | 2026-05-01 | To elect Directors - Nominees: S. C. Duhe | For | WITHHOLD — 6 of 6 T. Rowe Price funds | For | Elected, 95.4% support |
| United States Lime & Minerals, Inc. | 2026-05-01 | To elect Directors - Nominees: T. S. Hawkins, Jr. | For | WITHHOLD — 6 of 6 T. Rowe Price funds | For | Elected, 90.7% support |
| BKV Corp. | 2026-06-11 | Election of Class II Directors: Akaraphong Dayananda | Withhold | FOR — 6 of 6 T. Rowe Price funds | Against | Elected, 86.7% support |
| BKV Corp. | 2026-06-11 | Election of Class II Directors: Thiti Mekavichai | Withhold | FOR — 6 of 6 T. Rowe Price funds | Against | Elected, 86.7% support |
| CEVA, Inc. | 2026-06-02 | To elect seven directors, as specifically set forth in the proxy statement, to serve until the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified: Bernadette Andrietti | Against | FOR — 6 of 6 T. Rowe Price funds | Against | Elected, 94.9% support |
| CEVA, Inc. | 2026-06-02 | To elect seven directors, as specifically set forth in the proxy statement, to serve until the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified: Louis Silver | Against | FOR — 6 of 6 T. Rowe Price funds | Against | Elected, 95.8% support |
| CEVA, Inc. | 2026-06-02 | To elect seven directors, as specifically set forth in the proxy statement, to serve until the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified: Maria Marced | Against | FOR — 6 of 6 T. Rowe Price funds | Against | Elected, 95.7% support |
| Immunovant, Inc. | 2025-08-27 | To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Douglas Hughes | Withhold | FOR — 8 of 9 T. Rowe Price funds | Against | Elected, 89.5% support |
| Goosehead Insurance, Inc. | 2026-05-04 | Election of Directors: Robyn Jones | For | WITHHOLD — 7 of 8 T. Rowe Price funds | For | Elected, 77.3% support |
| Goosehead Insurance, Inc. | 2026-05-04 | Election of Directors: William Wade, Jr. | For | WITHHOLD — 7 of 8 T. Rowe Price funds | For | Elected, 77.3% support |
| Middlesex Water Company | 2026-05-19 | Election of Directors: Vaughn L. McKoy | For | WITHHOLD — 7 of 8 T. Rowe Price funds | For | Passed (calculated), 79.7% support |
| Vishay Precision Group, Inc. | 2026-05-19 | Election of Directors: Nava Swersky Sofer | For | WITHHOLD — 7 of 8 T. Rowe Price funds | For | — |
| Vishay Precision Group, Inc. | 2026-05-19 | Election of Directors: Saul Reibstein | For | WITHHOLD — 7 of 8 T. Rowe Price funds | For | — |
| Vishay Precision Group, Inc. | 2026-05-19 | Election of Directors: Sejal Shah Gulati | For | WITHHOLD — 7 of 8 T. Rowe Price funds | For | — |
| Texas Capital Bancshares, Inc. | 2026-04-21 | To elect ten (10) directors - each to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Thomas E. Long | For | WITHHOLD — 7 of 8 T. Rowe Price funds | For | Elected, 85.7% support |
| GPGI, Inc. | 2026-06-11 | Election of Directors: Brian F. Hughes | Withhold | FOR — 6 of 7 T. Rowe Price funds | Against | Passed (calculated), 97.8% support |
| GPGI, Inc. | 2026-06-11 | Election of Directors: Joseph J. DeAngelo | Withhold | FOR — 6 of 7 T. Rowe Price funds | Against | Passed (calculated), 99.8% support |
| GPGI, Inc. | 2026-06-11 | Election of Directors: Mark R. James | Withhold | FOR — 6 of 7 T. Rowe Price funds | Against | Passed (calculated), 92.2% support |
| OceanFirst Financial Corp. | 2026-04-02 | A proposal to approve the issuance of (a) OceanFirst common stock to holders of Flushing common stock (the "Flushing stockholders") pursuant to the merger agreement and (b) OceanFirst common stock, a new class of non-voting, common-equivalent stock of OceanFirst ("OceanFirst NVCE stock") and a warra | For | AGAINST — 6 of 7 T. Rowe Price funds | For | Approved, 94.3% support |
| Company | Meeting | Item | This fund | Most T. Rowe Price funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Equity Bancshares, Inc. | 2026-04-21 | Advisory vote to approve the compensation paid to the named executive officers of the Company. | Against | FOR — 8 of 10 T. Rowe Price funds | Against | Approved, 65.5% support |
| Kearny Financial Corp. | 2025-10-21 | The election of the five nominees listed, for the term indicated: Christopher Petermann, three-year term | For | WITHHOLD — 6 of 7 T. Rowe Price funds | For | Passed (calculated), 88.4% support |
| Kearny Financial Corp. | 2025-10-21 | The election of the five nominees listed, for the term indicated: John F. McGovern, three-year term | For | WITHHOLD — 6 of 7 T. Rowe Price funds | For | Passed (calculated), 86.2% support |
| Kearny Financial Corp. | 2025-10-21 | The election of the five nominees listed, for the term indicated: John J. Mazur, Jr., three-year term | For | WITHHOLD — 6 of 7 T. Rowe Price funds | For | Passed (calculated), 82.9% support |
| HarborOne Bancorp, Inc. | 2025-08-20 | A proposal to approve, on an advisory (non-binding) basis, specified compensation that may become payable to the named executive officers of HarborOne in connection with the merger (the "Merger-Related Compensation Proposal"); and | Against | FOR — 8 of 10 T. Rowe Price funds | Against | — |
| Cytokinetics, Incorporated | 2026-05-27 | 2 wordings Election of Class I Directors for terms expiring in 2029: Edward M. Kaye, M.D. | Withhold | FOR — 15 of 22 T. Rowe Price funds | Against | Passed (calculated), 97.0% support |
| Noble Corporation plc | 2026-04-29 | Authorization of the Board to Allot Shares without Rights of Pre-Emption. | Against | FOR — 7 of 9 T. Rowe Price funds | Against | Approved, 81.0% support |
| Noble Corporation plc | 2026-04-29 | Authorization of the Board to Allot Shares. | Against | FOR — 7 of 9 T. Rowe Price funds | Against | — |
| Adaptive Biotechnologies Corporation | 2026-06-05 | To elect two Class I director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2029 annual meeting of shareholders: Robert Hershberg, PhD, MD | For | WITHHOLD — 7 of 9 T. Rowe Price funds | For | — |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: Jody A. Markopoulos | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Passed (calculated), 100.0% support |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: John W. Kuo | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Passed (calculated), 100.0% support |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: Kenneth C. Bockhorst | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Passed (calculated), 100.0% support |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: Lawrence D. Kingsley | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Passed (calculated), 100.0% support |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: Robert A. Cascella | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Passed (calculated), 100.0% support |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: Sheila Rege | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Passed (calculated), 100.0% support |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: Steven W. Etzel | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Passed (calculated), 100.0% support |
| Mercury Systems, Inc. | 2025-10-22 | To elect three Class I directors nominated by the Board of Directors, each to serve for a three-year term, and in each case until their successors have been duly elected and qualified: Howard L. Lance | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | — |
| Mercury Systems, Inc. | 2025-10-22 | To elect three Class I directors nominated by the Board of Directors, each to serve for a three-year term, and in each case until their successors have been duly elected and qualified: Lisa S. Disbrow | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | — |
| Applied Optoelectronics, Inc. | 2026-06-04 | Class I Directors for Election: Che-Wei Lin | For | WITHHOLD — 7 of 9 T. Rowe Price funds | For | — |
| Applied Optoelectronics, Inc. | 2026-06-04 | Class I Directors for Election: Robert (Bob) Flanagan | For | WITHHOLD — 7 of 9 T. Rowe Price funds | For | — |
| Miami International Holdings, Inc. | 2026-06-16 | The election of the 15 director nominees: Talal Jassim Al-Bahar | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Passed (calculated), 75.7% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Blake W. Augsburger | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Elected, 97.4% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Denis G. Suggs | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Elected, 93.5% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: John A. Forbes | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Elected, 92.6% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Joseph M. Cerulli | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Elected, 83.6% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: M. Scott Welch | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Elected, 93.4% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Michael A. Kitson | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Elected, 96.3% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Natalie A. Brown | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Elected, 94.3% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Todd M. Cleveland | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Elected, 96.5% support |
| Peloton Interactive, Inc. | 2025-12-09 | Election of Directors: Chris Bruzzo | For | WITHHOLD — 7 of 9 T. Rowe Price funds | For | Elected, 77.8% support |
| Root, Inc. | 2026-06-03 | To elect three Class III directors, Lawrence Hilsheimer, Alexander Timm and Douglas Ulman, each to hold office until our Annual Meeting of Stockholders in 2029: Lawrence Hilsheimer | For | AGAINST — 7 of 9 T. Rowe Price funds | For | Elected, 92.8% support |
| CRISPR Therapeutics AG | 2026-06-04 | Binding vote on maximum equity for members of the Executive Committee from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders. | Against | FOR — 5 of 6 T. Rowe Price funds | Against | — |
| CRISPR Therapeutics AG | 2026-06-04 | Binding vote on maximum non-performance-related compensation for members of the Executive Committee from July 1, 2026 to June 30, 2027. | Against | FOR — 5 of 6 T. Rowe Price funds | Against | — |
| CRISPR Therapeutics AG | 2026-06-04 | Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2026. | Against | FOR — 5 of 6 T. Rowe Price funds | Against | — |
| CRISPR Therapeutics AG | 2026-06-04 | Non-binding advisory vote on the 2025 Compensation Report. | Against | FOR — 5 of 6 T. Rowe Price funds | Against | — |
| CRISPR Therapeutics AG | 2026-06-04 | Re-election of Ali Behbahani, M.D. | For | AGAINST — 5 of 6 T. Rowe Price funds | For | — |
| CRISPR Therapeutics AG | 2026-06-04 | Re-election of the members of the Compensation Committee: Re-election of Ali Behbahani, M.D. | For | AGAINST — 5 of 6 T. Rowe Price funds | For | — |
| IonQ, Inc. | 2026-06-16 | To elect two Class II directors to hold office until our 2029 Annual Meeting of Stockholders and until a successor is duly elected and qualified or until earlier resignation or removal: Kathryn K. Chou | Withhold | FOR — 6 of 8 T. Rowe Price funds | Against | Elected, 71.3% support |
| IonQ, Inc. | 2026-06-16 | To elect two Class II directors to hold office until our 2029 Annual Meeting of Stockholders and until a successor is duly elected and qualified or until earlier resignation or removal: William F. Scannell | Withhold | FOR — 6 of 8 T. Rowe Price funds | Against | Elected, 83.0% support |
| CRISPR Therapeutics AG | 2026-06-04 | Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements. | Against | FOR — 6 of 8 T. Rowe Price funds | Against | Approved, 69.4% support |
| Kadant Inc. | 2026-05-20 | Election of two directors to the class to be elected for a three-year term expiring in 2029: Thomas C. Leonard | Against | FOR — 6 of 8 T. Rowe Price funds | Against | — |
| Surgery Partners, Inc. | 2026-06-05 | Election of Class II Directors: Brent Turner | Withhold | FOR — 6 of 8 T. Rowe Price funds | Against | Elected, 96.9% support |
| PBF Energy Inc. | 2026-04-28 | Election of Directors: Spencer Abraham | Against | FOR — 7 of 10 T. Rowe Price funds | Against | Elected, 89.4% support |
| ESCO Technologies Inc. | 2026-01-30 | Election of Directors: Patrick M. Dewar | Withhold | FOR — 7 of 10 T. Rowe Price funds | Against | Elected, 96.4% support |
| ESCO Technologies Inc. | 2026-01-30 | Election of Directors: Vinod M. Khilnani | Withhold | FOR — 7 of 10 T. Rowe Price funds | Against | Elected, 96.6% support |
| Flagstar Bank, N.A. | 2026-06-09 | Election of Directors: Marshall Lux | Against | FOR — 7 of 10 T. Rowe Price funds | Against | Elected, 98.0% support |
| Ambarella, Inc. | 2026-06-26 | Election of Directors: D. Jeffrey Richardson | Withhold | FOR — 7 of 10 T. Rowe Price funds | Against | Elected, 89.0% support |
| Ambarella, Inc. | 2026-06-26 | Election of Directors: Elizabeth M. Schwarting | Withhold | FOR — 7 of 10 T. Rowe Price funds | Against | Elected, 80.4% support |
| Oscar Health, Inc. | 2026-06-04 | Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: David Alexander Plouffe | Withhold | FOR — 8 of 12 T. Rowe Price funds | Against | Passed (calculated), 99.5% support |
| Oscar Health, Inc. | 2026-06-04 | Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: Siddhartha Sankaran | Withhold | FOR — 8 of 12 T. Rowe Price funds | Against | Passed (calculated), 99.7% support |
| Oscar Health, Inc. | 2026-06-04 | Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: William (Bill) J. Gassen III | Withhold | FOR — 8 of 12 T. Rowe Price funds | Against | Passed (calculated), 96.9% support |
| Miami International Holdings, Inc. | 2026-06-16 | The approval, on a non-binding advisory basis, of the compensation of our named executive officers. | Against | FOR — 8 of 12 T. Rowe Price funds | Against | Passed (calculated), 73.9% support |
| Flagstar Bank, N.A. | 2026-06-09 | An advisory vote to approve, on a non-binding basis, compensation of our named executive officers disclosed in the accompanying proxy statement. | Against | FOR — 8 of 13 T. Rowe Price funds | Against | Passed (calculated), 81.2% support |
| Advanced Energy Industries, Inc. | 2026-05-07 | Approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan; and | Against | FOR — 6 of 9 T. Rowe Price funds | Against | Approved, 78.4% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Amin N. Maredia | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 98.7% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Edward N. Antoian | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 97.6% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Harry S. Cherken, Jr. | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 98.4% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: John C. Mulliken | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 97.7% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Kelly Campbell | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 99.3% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Mary C. Egan | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 98.7% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Todd R. Morgenfeld | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 99.1% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Wesley S. McDonald | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 98.3% support |
| Interparfums, Inc. | 2025-09-10 | To vote for the advisory resolution to approve executive compensation. | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Approved, 84.3% support |
| Marqeta, Inc. | 2026-06-10 | To approve an amendment to our Amended and Restated Certificate of Incorporation to provide for officer exculpation as permitted by Delaware law. | For | AGAINST — 7 of 11 T. Rowe Price funds | For | Passed (calculated), 78.7% support |
| Marqeta, Inc. | 2026-06-10 | To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Judson (Jud) Li | For | WITHHOLD — 7 of 11 T. Rowe Price funds | For | Passed (calculated), 92.2% support |
| Marqeta, Inc. | 2026-06-10 | To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Martha Cummings | For | WITHHOLD — 7 of 11 T. Rowe Price funds | For | Passed (calculated), 82.1% support |
| Marqeta, Inc. | 2026-06-10 | To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Najuma Atkinson | For | WITHHOLD — 7 of 11 T. Rowe Price funds | For | Passed (calculated), 87.8% support |
| Marqeta, Inc. | 2026-06-10 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | For | AGAINST — 8 of 14 T. Rowe Price funds | For | Passed (calculated), 78.5% support |
| MapLight Therapeutics, Inc. | 2026-06-23 | To elect the three Class I Director nominees named in the Proxy Statement to serve until the 2029 annual meeting of our stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Martin Babler | For | WITHHOLD — 8 of 14 T. Rowe Price funds | For | — |
| Installed Building Products, Inc. | 2026-05-19 | Election of Directors to serve for three-year terms: Robert H. Schottenstein | Against | FOR — 7 of 12 T. Rowe Price funds | Against | Elected, 93.9% support |
| Xenon Pharmaceuticals Inc. | 2026-06-02 | To approve the Corporation's 2026 Equity Incentive Plan; | Against | FOR — 7 of 12 T. Rowe Price funds | Against | Approved, 68.0% support |
| Kodiak Sciences Inc. | 2026-06-02 | Elect three Class II directors nominated by our board and named in this proxy statement: Charles A. Bancroft | For | WITHHOLD — 8 of 15 T. Rowe Price funds | For | Elected, 78.7% support |
| Denali Therapeutics Inc. | 2026-06-03 | ELECTION OF DIRECTORS: David Schenkein, M.D. | For | WITHHOLD — 8 of 15 T. Rowe Price funds | For | Elected, 73.5% support |
| Denali Therapeutics Inc. | 2026-06-03 | ELECTION OF DIRECTORS: Jennifer Cook | For | WITHHOLD — 8 of 15 T. Rowe Price funds | For | Elected, 60.9% support |
| Impinj, Inc. | 2026-05-28 | Election of Directors: Steve Sanghi | For | AGAINST — 7 of 13 T. Rowe Price funds | For | Elected, 68.1% support |
| NovoCure Limited | 2026-06-03 | The approval of our amended and restated 2024 Omnibus Incentive Plan. | Against | FOR — 2 of 3 T. Rowe Price funds | Against | Approved, 50.3% support |
Download all 101 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 90.0% of this fund’s 15,764 such votes could be given a sector; the other 1,570 (10.0%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Finance | 3,179 | 17 | 0.5% |
| Consumer Discretionary | 2,755 | 24 | 0.9% |
| Health Care | 2,435 | 11 | 0.5% |
| Industrials | 1,583 | 5 | 0.3% |
| Technology | 1,432 | 4 | 0.3% |
| Real Estate | 886 | 1 | 0.1% |
| Energy | 615 | 0 | 0.0% |
| Utilities | 384 | 0 | 0.0% |
| Consumer Staples | 265 | 5 | 1.9% |
| Basic Materials | 245 | 0 | 0.0% |
| Miscellaneous | 210 | 0 | 0.0% |
| Telecommunications | 205 | 1 | 0.5% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 10,669 | 33 |
| Audit-related | 1,858 | 3 |
| Say-on-Pay | 1,856 | 4 |
| Compensation | 646 | 2 |
| Corporate Governance | 457 | 17 |
| Capital Structure | 226 | 3 |
| Extraordinary Transactions | 203 | 4 |
| Shareholder Rights and Defenses | 49 | 1 |
| Other Social Issues | 3 | 0 |
| Diversity, Equity, and Inclusion | 2 | 2 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| agilon health, inc. | March 17, 2026 | $5M | 2 | 0 |
| Bloom Energy Corporation | May 21, 2026 | $5M | 8 | 0 |
| Guardant Health, Inc. | June 17, 2026 | $2M | 5 | 0 |
| Glaukos Corporation | May 28, 2026 | $2M | 4 | 0 |
| BridgeBio Pharma, Inc. | June 22, 2026 | $1M | 7 | 0 |
| The Ensign Group, Inc. | May 13, 2026 | $1M | 6 | 0 |
| American Healthcare REIT, Inc. | June 24, 2026 | $1M | 11 | 0 |
| Semtech Corporation | June 4, 2026 | $1M | 12 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| March 9, 2026 | Sanmina Corporation | To consider and vote upon the stockholder proposal entitled "Independent Board Chairman," requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposal | Against | For |
| April 28, 2026 | The Brink's Company | Act upon a shareholder proposal requesting a report on employee retention rates by demographic categories. Shareholder proposal | Against | For |
| May 13, 2026 | ICU Medical, Inc. | To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Shareholder proposal | Against | For |
| May 21, 2026 | Meritage Homes Corporation | Shareholder proposal to improve shareholder ability to call for a special shareholder meeting. Shareholder proposal | Against | For |
| May 4, 2026 | Asbury Automotive Group, Inc. | Stockholder proposal regarding special stockholder meetings. Shareholder proposal | Against | For |
| May 20, 2026 | Lumen Technologies, Inc. | Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill. Shareholder proposal | For | Against |
| May 5, 2026 | SkyWest, Inc. | A shareholder proposal regarding collective bargaining policy. Shareholder proposal | Against | For |
| May 12, 2026 | Group 1 Automotive, Inc. | Shareholder Proposal: Give Shareholders an Ability to Call for a Special Shareholder Meeting. Shareholder proposal | Against | For |
| April 24, 2026 | ArcBest Corporation | A shareholder proposal to approve GHG emissions reduction targets, if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
| December 15, 2025 | UniFirst Corporation | To elect two Class II directors, each to serve for a term of three years until the 2029 annual meeting of shareholders and until their respective successors are duly elected and qualified: Arnaud Ajdler Shareholder proposal | For | Against |
| December 15, 2025 | UniFirst Corporation | To elect two Class II directors, each to serve for a term of three years until the 2029 annual meeting of shareholders and until their respective successors are duly elected and qualified: Michael A. Croatti Shareholder proposal | For | Against |
| June 3, 2026 | Resideo Technologies, Inc. | Shareholder Proposal Regarding Shareholder Right to Act by Written Consent. Shareholder proposal | Against | For |
Meetings with a proxy contest or competing nominees (13 in 2025-2026), and how the fund voted the items on its ballot.
15,976 ballot items at 2,078 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, T. Rowe Price Small-Cap Index Fund (TRCSX) voted at 2,078 shareholder meetings of 1,959 companies, on 15,976 ballot items in all. Where management made a recommendation, the fund followed it on 99.5% of the items and voted against it 73 times. Its most frequent area of disagreement was director elections (33 of its votes against management). It voted on 56 shareholder proposals. It voted FOR the board's own proposals less often than T. Rowe Price's funds as a whole (87.2% against 93.7%). It voted differently from most T. Rowe Price funds on 101 items. 13 of its meetings were contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of T. Rowe Price’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.